CBD reduced the negative emotional effects of opioid withdrawal in rats through serotonin receptors
CBD blocked the development of conditioned place aversion during naloxone-triggered morphine withdrawal in rats, and this effect depended on 5-HT1A serotonin receptor activation.
Quick Facts
What This Study Found
CBD (5 and 20 mg/kg) prevented conditioned place aversion induced by naloxone-precipitated morphine withdrawal. Pre-treatment with a 5-HT1A antagonist (WAY100635) blocked this effect, indicating serotonin receptor involvement.
Key Numbers
CBD doses of 5 and 20 mg/kg attenuated conditioned place aversion. 5-HT1A antagonist WAY100635 reversed the CBD effect, confirming serotonin receptor involvement.
How They Did This
Conditioned place aversion paradigm in rats. Animals received morphine for dependence, then naloxone to trigger withdrawal paired with a specific compartment. CBD was administered before withdrawal sessions. 5-HT1A antagonist used to test mechanism.
Why This Research Matters
Opioid withdrawal creates powerful negative emotional memories that drive relapse. If CBD can reduce the aversive quality of withdrawal through serotonin pathways, it could complement existing addiction treatments.
The Bigger Picture
The opioid crisis continues to claim lives, and existing medications for opioid use disorder, while effective, are underutilized and stigmatized. Non-opioid treatments that address the emotional dimensions of withdrawal could expand the therapeutic toolkit.
What This Study Doesn't Tell Us
Animal study with no direct human applicability. Conditioned place aversion is a behavioral proxy for withdrawal discomfort, not a direct measure. Doses and routes of CBD administration in rats do not translate directly to human dosing.
Questions This Raises
- ?Would CBD produce similar effects during natural (non-naloxone-precipitated) opioid withdrawal?
- ?Can these findings be replicated in human clinical trials of opioid dependence?
Trust & Context
- Key Stat:
- CBD at 5 and 20 mg/kg blocked withdrawal-induced place aversion via 5-HT1A receptors
- Evidence Grade:
- Well-designed animal study with mechanistic investigation. However, animal findings frequently do not translate to human outcomes.
- Study Age:
- Published 2022.
- Original Title:
- Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.
- Published In:
- Behavioural brain research, 450, 114504 (2023)
- Authors:
- Souza, Adriana Jesus, Guimarães, Francisco S(18), Gomes, Felipe V(4)
- Database ID:
- RTHC-04954
Evidence Hierarchy
Frequently Asked Questions
Could CBD help people going through opioid withdrawal?
This rat study provides a biological rationale for how CBD might reduce the emotional distress of opioid withdrawal. Some early human studies have also explored CBD for opioid cravings. However, animal results often do not translate to clinical practice, and much more human research is needed.
What is conditioned place aversion?
It is a laboratory test where an animal learns to avoid a location associated with an unpleasant experience (in this case, opioid withdrawal). If CBD prevents this avoidance learning, it suggests the withdrawal experience was perceived as less unpleasant.
Read More on RethinkTHC
- 30-days-without-weed
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- creativity-without-weed-quitting-artist-musician
- hobbies-after-quitting-weed
- identity-after-quitting-weed
- leaving-stoner-culture-identity
- medical-benefits-of-cannabis
- money-saved-quitting-weed-calculator
- one-year-sober-weed
- quitting-weed-before-surgery
- quitting-weed-creativity
- quitting-weed-face-changes-skin
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- quitting-weed-weight-loss-gain
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04954APA
Souza, Adriana Jesus; Guimarães, Francisco S; Gomes, Felipe V. (2023). Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.. Behavioural brain research, 450, 114504. https://doi.org/10.1016/j.bbr.2023.114504
MLA
Souza, Adriana Jesus, et al. "Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.." Behavioural brain research, 2023. https://doi.org/10.1016/j.bbr.2023.114504
RethinkTHC
RethinkTHC Research Database. "Cannabidiol attenuates the expression of conditioned place a..." RTHC-04954. Retrieved from https://rethinkthc.com/research/souza-2023-cannabidiol-attenuates-the-expression
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.